NIH-funded research NIH-funded research

Exploring how small RNA molecules regulate gene expression in cells

Official title: Understanding what regulates a regulator: the molecular basis for homeostatic small RNA-mediated gene regulation

Funded at University of Texas Arlington · NIH-11143233 · Data updated 2026-11-12

This study is looking at how tiny molecules in our cells help control genes, which could help us understand more about genetic diseases and cancer, so patients can learn how these processes might affect their health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas Arlington
NIH-funded
Lab location1 site (Arlington, United States)
Project startAugust 1, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$373,397
NIH project number5R35GM155429-02
Project IDNIH-11143233 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with genetic disorders, cancers, or conditions related to mis-regulated gene expression.

Less likely to help

Patients with conditions unrelated to RNA interference or gene regulation may not receive any benefit from this research.

What this research studies

This research investigates the role of RNA interference (RNAi) pathways, which are essential for regulating gene expression in cells. By studying how small RNA molecules interact with Argonaute proteins, the research aims to understand the mechanisms that maintain balance in gene regulation. The approach involves creating novel mutants to observe the effects of disrupting RNAi homeostasis, which could reveal insights into genetic diseases, cancer, and other health issues. Patients may benefit from a deeper understanding of how gene regulation impacts their conditions.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating genetic diseases and cancers by restoring proper gene regulation.

How similar studies have gone: Previous research has shown promising results in understanding RNAi pathways, indicating that this approach could lead to significant advancements in gene regulation therapies.

Where this research is happening

  • University of Texas Arlington
    Arlington, United States
    Active

Researchers

  • Principal investigator: Rogers, Alicia Kathryn — University of Texas Arlington
  • Study coordinator: Rogers, Alicia Kathryn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.